A203690 Stock Overview
Engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Ark Solutions Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,530.00 |
| 52 Week High | ₩14,040.00 |
| 52 Week Low | ₩4,435.00 |
| Beta | 0.58 |
| 11 Month Change | -11.18% |
| 3 Month Change | -27.52% |
| 1 Year Change | -51.81% |
| 33 Year Change | -66.51% |
| 5 Year Change | -74.30% |
| Change since IPO | -85.36% |
Recent News & Updates
Sphere Power (KOSDAQ:203690) Is Carrying A Fair Bit Of Debt
Jul 31
Lacklustre Performance Is Driving Sphere Power Inc.'s (KOSDAQ:203690) 25% Price Drop
Jun 20Investors Don't See Light At End Of Sphere Power Inc.'s (KOSDAQ:203690) Tunnel And Push Stock Down 29%
May 06Recent updates
Sphere Power (KOSDAQ:203690) Is Carrying A Fair Bit Of Debt
Jul 31Lacklustre Performance Is Driving Sphere Power Inc.'s (KOSDAQ:203690) 25% Price Drop
Jun 20Investors Don't See Light At End Of Sphere Power Inc.'s (KOSDAQ:203690) Tunnel And Push Stock Down 29%
May 06Further Upside For Sphere Power Inc. (KOSDAQ:203690) Shares Could Introduce Price Risks After 44% Bounce
Mar 21Sphere Power Inc. (KOSDAQ:203690) Soars 44% But It's A Story Of Risk Vs Reward
Mar 21Would Prostemics (KOSDAQ:203690) Be Better Off With Less Debt?
Apr 13What Type Of Returns Would Prostemics'(KOSDAQ:203690) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Feb 17
Do Institutions Own Prostemics Co., Ltd. (KOSDAQ:203690) Shares?
Dec 22Shareholder Returns
| A203690 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -8.9% | -8.1% | 2.9% |
| 1Y | -51.8% | 18.1% | -2.8% |
Return vs Industry: A203690 underperformed the KR Biotechs industry which returned 21.1% over the past year.
Return vs Market: A203690 underperformed the KR Market which returned -4% over the past year.
Price Volatility
| A203690 volatility | |
|---|---|
| A203690 Average Weekly Movement | 7.3% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A203690 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A203690's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 67 | Won-Jong Lee | www.prostemics.co.kr |
Ark Solutions Inc. engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally. It operates through Life and Health Business and Exosome Business divisions. The company offers products using stem cells.
Ark Solutions Inc Fundamentals Summary
| A203690 fundamental statistics | |
|---|---|
| Market cap | ₩59.66b |
| Earnings (TTM) | -₩21.08b |
| Revenue (TTM) | ₩32.99b |
1.8x
P/S Ratio-2.8x
P/E RatioIs A203690 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A203690 income statement (TTM) | |
|---|---|
| Revenue | ₩32.99b |
| Cost of Revenue | ₩33.56b |
| Gross Profit | -₩567.81m |
| Other Expenses | ₩20.51b |
| Earnings | -₩21.08b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.60k |
| Gross Margin | -1.72% |
| Net Profit Margin | -63.89% |
| Debt/Equity Ratio | 92.6% |
How did A203690 perform over the long term?
See historical performance and comparison